Drug approval: Crizotinib in unresectable or refractory ALK-positive pediatric inflammatory myofibroblastic tumors

被引：0
作者：
Tenaillon, Anne [1 ]
Orbach, Daniel [1 ]
机构：
[1] Inst Curie, Ctr Integre Soins & Rech Oncol Enfant Adolescent &, 26 rue Ulm, F-75005 Paris, France
来源：
BULLETIN DU CANCER | 2023年 / 110卷 / 04期
关键词：
Inflammatory myofibroblastic tumor; Targeted therapy; ALK-positive; Crizotinib; Children;
D O I：
10.1016/j.bulcan.2022.12.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：248 / 249
页数：2
相关论文
共 50 条
  • [21] A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients
    Dikopf, Alana
    Wood, Kevin
    Salgia, Ravi
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (03) : 485 - 493
  • [22] Crizotinib Efficacy in ALK-Positive Advanced NSCLC Chinese Patients
    Cui, Shaohua
    Zhao, Yizhuo
    Gu, Aiqin
    Ge, Xiaoxiao
    Song, Yanyan
    Zhang, Wei
    Lou, Yuqing
    Dong, Lili
    Han, Baohui
    Jiang, Liyan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S412 - S412
  • [23] Pediatric Non-Myofibroblastic Primitive Spindle Cell Tumors with ALK Gene Rearrangements and Response to Crizotinib
    Rakheja, Dinesh
    Park, Jason Y.
    Fernandes, Neil J.
    Watt, Tanya C.
    Laetsch, Theodore W.
    Collins, Rebecca R. J.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2022, 30 (06) : 706 - 715
  • [24] Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangement
    Rafee, Shereen
    Elamin, Yasir Y.
    Joyce, Eimear
    Toner, Mary
    Flavin, Richard
    McDermott, Ronan
    Sheehy, Niall
    Hennessy, Bryan
    O'Byrne, Kenneth
    Gleeson, Noreen
    Osman, Nemer
    TUMORI, 2015, 101 (02) : E35 - E39
  • [25] Treatment modalities of ALK-positive relapsed/refractory inflammatory myofibroblastic tumor of the brain and lungs in 7-year-old girl: case-based reviews
    Chanthong, Supapitch
    Sathitsamitphong, Lalita
    Natesirinilkul, Rungrote
    Charoenkwan, Pimlak
    Suwansirikul, Songkiet
    Choed-Amphai, Chane
    CHILDS NERVOUS SYSTEM, 2023, 39 (02) : 331 - 342
  • [26] Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor
    Bonvini, Paolo
    Rossi, Elisabetta
    Zin, Angelica
    Manicone, Mariangela
    Vidotto, Riccardo
    Facchinetti, Antonella
    Tombolan, Lucia
    Affinita, Maria Carmen
    Santoro, Luisa
    Zamarchi, Rita
    Bisogno, Gianni
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [27] Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma
    Amr Fadl
    Andrew L. Feldman
    Journal of Hematopathology, 2023, 16 : 125 - 126
  • [28] Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma
    Fadl, Amr
    Feldman, Andrew L.
    JOURNAL OF HEMATOPATHOLOGY, 2023, 16 (02) : 125 - 126
  • [29] ALK-Positive Inflammatory Myofibroblastic Tumor of the Nipple During Pregnancy-An Unusual Presentation of a Rare Disease
    Kovacs, Aniko
    Mathe, Gyongyver
    Mattsson, Jan
    Stenman, Goran
    Kindblom, Lars-Gunnar
    BREAST JOURNAL, 2015, 21 (03) : 297 - 302
  • [30] Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer
    Ji, Cheng
    Zhang, Li
    Cheng, Yan
    Patel, Raj
    Wu, Hao
    Zhang, Yi
    Wang, Mian
    Ji, Shundong
    Belani, Chandra P.
    Yang, Jin-Ming
    Ren, Xingcong
    CANCER BIOLOGY & THERAPY, 2014, 15 (05) : 570 - 577
12345